RFC
LPCN icon

Russell Frank Company’s Lipocine LPCN Stock Holding History

Russell Frank Company’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$824K Sell
4,774
-966
-17% -$165K ﹤0.01% 2257
2015
Q4 		$1.26M Buy
5,740
+418
+8% +$87.7K ﹤0.01% 2094
2015
Q3 		$1.07M Buy
+5,322
New +$1.23M ﹤0.01% 2168

Other funds holding LPCN

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Russell Frank Company's LPCN Position: Q1 2016 in Review

Russell Frank Company reduced its Lipocine (LPCN) stake by 17% in Q1 2016, selling an estimated $165K and leaving 4,774 shares worth $824K. The position accounts for ﹤0.01% of the portfolio, ranked #2257.

Russell Frank Company first reported a position in LPCN in Q3 2015 and has held it in 3 quarters since. The position peaked at $1.26M in Q4 2015. 53 funds tracked by Wall St. Rank hold LPCN as of Q1 2016.

  • Russell Frank Company held 4,774 shares of Lipocine worth $824K as of Q1 2016.
  • Russell Frank Company sold 966 Lipocine shares in Q1 2016, an estimated $165K.
  • Lipocine made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2257 holding.
  • Russell Frank Company first reported a position in Lipocine in Q3 2015 and has held it in 3 quarters since.
  • Russell Frank Company's Lipocine position peaked at $1.26M in Q4 2015.
  • 53 funds tracked by Wall St. Rank held Lipocine as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.